Get Started in Minutes
How Entyvio Copay Assistance Works
1 – Check Your Coverage/Benefits Verification
Our team of expert billers finds the best avenues of coverage that minimize out-of-pocket costs.
2 – Transfer Prescription to AmeriPharma
We process your prescription by working with your previous pharmacy or prescriber, making the transition quick and easy.
3 – Prior Authorization
Our team of specialists obtains approval from your insurance companies within 24 to 72 hours.
4 – Copay Assistance & Financial Aid
We secure financial aid and decrease copays, out-of-pocket expenses, and high deductibles. To date, AmeriPharma Specialty Care has secured $55 million in financial assistance for our patients.
5 – Nursing Care Coordination
AmeriPharma puts your schedule and home environment first when scheduling and coordinating one of our specialized nurses for your in-home infusions.
6 – Delivery Coordination
Medications are always delivered in strict compliance with the specific requirements for immune globulin shipping. Next-day and overnight cold-chain deliveries are coordinated around your schedule.
What Is Entyvio?
Entyvio (vedolizumab) is a prescription medication known as an integrin receptor antagonist. Entyvio is indicated for inflammatory bowel diseases such as Crohn’s disease and ulcerative colitis.
Entyvio is an antibody that helps reduce inflammation in the gut. It is used in patients that suffer from moderate to severe ulcerative colitis and moderate to severe Crohn’s disease. Entyvio is administered as an intravenous infusion over 30 minutes, and it is recommended to be administered by a healthcare professional for monitoring purposes. Patients must be observed during the infusion and when the infusion is complete. Before initiation of Entyvio, it is necessary for patients to be up to date on all immunizations.
How Is Entyvio Used?
Entyvio is a humanized monoclonal antibody that is used in inflammatory bowel diseases. It is used in order to help with reducing gastrointestinal inflammation that is caused by ulcerative colitis and Crohn’s disease.
Ulcerative colitis affects the lining of the large intestine and may cause ulcers. There is no cure, however, medications such as Entyvio can help reduce the inflammation that is caused by the increase in white blood cells.
Crohn’s disease also causes swelling of the digestive tract. Entyvio functions by preventing an overabundance of white blood cells from entering the gastrointestinal tract. This leads to a decrease in the inflammation that is caused by these disease states.
Copay and Financial Assistance
AmeriPharma Specialty Care alleviates financial burdens for patients and their families
Advanced software locates funding sources to match you with top-dollar foundation programs
One of our copay assistance specialists will assist with the application process
Automatic updates will be sent to you and your physician on the status of the funding
Entyvio Side Effects
Entyvio may increase the chance of developing infections. It can also cause progressive multifocal leukoencephalopathy (PML) which is a serious neurological disease. This can lead to confusion, memory problems, trouble in balance, or a change in eyesight. Liver injury may also occur with this medication.
Other side effects include:
- Back pain
- Signs of a common cold
- Joint pain
- Upset stomach
- Nose or throat irritation
- Pain in arms or legs
- Feeling tired or weak
- Shortness of breath
- Fast or abnormal heartbeat
Entyvio comes in a 300 mg single-dose vial. The recommended dose discussed below pertains to both ulcerative colitis and Crohn’s disease.
It is recommended that 300 mg be infused intravenously over 30 minutes at zero, two, and six weeks. It should be administered every 8 weeks thereafter. By week 14, if the patient does not see therapeutic benefit, Entyvio should be discontinued.
Entyvio should be infused by a healthcare professional and monitored for anaphylaxis. Entyvio is diluted in 0.9% sodium chloride or lactated Ringers. After dilution, Entyvio is stable for 12 hours at room temperature and 24 hours when refrigerated.
This medication is usually ordered by the doctor and sent to the doctor’s office to be administered. Hypersensitivity or infusion reactions may occur during administration, so it is very important that this medication be administered by a healthcare professional. It has also been reported that this medication causes upper respiratory tract infections. It is necessary to be up to date on vaccinations prior to the administration of this medication. Before the administration of Entyvio, report all medications taken in case of a drug interaction.
Entyvio is not recommended in patients who are experiencing infections and should be given after infections have been controlled.